By Zachary Stieber 2020 Sept. 22, 2020: U.S. Centers for Disease Control and Prevention (CDC) identifies myocarditis as an adverse event of special interest, or a potential side effect. Oct. 30, 2020: U.S. Food and Drug Administration (FDA) identifies myocarditis as an adverse event of special interest. December 2020: One case of pericarditis reported to the U.S. Vaccine Adverse Event […]
Tag: Myopericarditis
Myopericarditis is a condition characterized by inflammation of the pericardium (pericarditis) with concurrent involvement of the adjacent myocardial layer. Myopericarditis usually presents similarly to pericarditis with chest pain, fever, and shortness of breath.
